Study Summary
This trial tests a 6-week online course to help Black breast cancer survivors with physical activity, goal setting, nutrition, sleep, stress, and social connections.
- Breast Cancer
Treatment Effectiveness
Effectiveness Progress
Study Objectives
6 Primary · 5 Secondary · Reporting Duration: 6 weeks
Trial Safety
Safety Progress
Trial Design
1 Treatment Group
Breast Cancer Survivor Education Program
1 of 1
Experimental Treatment
15 Total Participants · 1 Treatment Group
Primary Treatment: Breast Cancer Survivor Education Program · No Placebo Group · N/A
Trial Logistics
Trial Timeline
Who is running the clinical trial?
Eligibility Criteria
Age 18+ · Female Participants · 6 Total Inclusion Criteria
Mark “Yes” if the following statements are true for you:Frequently Asked Questions
Are there any vacancies that participants can join in this clinical research?
"Data hosted on clinicaltrials.gov affirms that enrollment for this particular trial was closed as of January 17th 2023 and is no longer accepting patients at the moment. Despite this, there are currently over 2500 other studies actively recruiting participants." - Anonymous Online Contributor
What purposes does this trial seek to achieve?
"According to the Pfizer-sponsored trial, their primary endpoint is Time Required to Recruit to Target and will be monitored over a 6 week period. Additionally, secondary outcomes being observed include Intention to Receive post-treatment Surveillance Mammography (via FOCUS Survey), Physical Activity Goal Change (also via FOCUS Survey) and Dietary Behavior Goal Change (again with the help of the FOCUS survey)." - Anonymous Online Contributor